Edition:
India

CanniMed Therapeutics Inc (CMED.TO)

CMED.TO on Toronto Stock Exchange

34.77CAD
19 Jan 2018
Change (% chg)

$2.17 (+6.66%)
Prev Close
$32.60
Open
$32.00
Day's High
$35.90
Day's Low
$32.00
Volume
1,166,593
Avg. Vol
206,967
52-wk High
$35.90
52-wk Low
$7.32

Chart for

About

CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of... (more)

Overall

Beta: --
Market Cap(Mil.): $261.62
Shares Outstanding(Mil.): 22.67
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike: sources

TORONTO Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to buy both businesses in a friendly deal that would create the nation's top weed company, people familiar with the matter told Reuters on Friday.

20 Jan 2018

UPDATE 1-Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike -sources

TORONTO, Jan 19 Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to buy both businesses in a friendly deal that would create the nation's top weed company, people familiar with the matter told Reuters on Friday.

20 Jan 2018

Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike -sources

TORONTO, Jan 19 Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to acquire both companies in a friendly deal, people familiar with the situation told Reuters on Friday.

20 Jan 2018

Canadian cannabis firm CanniMed in talks with suitor Aurora

TORONTO Canadian cannabis producer CanniMed Therapeutics Inc said it has postponed a shareholder vote on its proposed takeover of Newstrike Resources Ltd to allow it to discuss a possible transaction with hostile suitor Aurora Cannabis Inc .

19 Jan 2018

CanniMed in talks with Aurora, postpones shareholder vote on Newstrike deal

TORONTO, Jan 18 Canadian cannabis producer CanniMed Therapeutics Inc has postponed to Jan. 25 a shareholder vote on its proposed takeover of Newstrike Resources Ltd in order to discuss a possible transaction with rival producer Aurora Cannabis Inc.

18 Jan 2018

REFILE-Up Cannabis-parent Newstrike's shareholders approve sale to CanniMed

Jan 17 Newstrike Resources Ltd's shareholders approved the sale of the Canadian cannabis producer to CanniMed Therapeutics Inc, which is fighting off a hostile takeover bid from fellow medical marijuana company Aurora Cannabis Inc.

18 Jan 2018

BRIEF-‍Senvest Management Says Proposed Price Under Aurora Cannabis's Bid "Significantly Undervalues" CanniMed

* SENVEST MANAGEMENT LLC EXPRESSES CONCERNS REGARDING THE TERMS OF AURORA CANNABIS, INC’S TAKEOVER BID FOR CANNIMED THERAPEUTICS INC IN LETTER TO THE BOARD; ANNOUNCES VOTING AND TENDER INTENTIONS

17 Jan 2018

BRIEF-Cannimed Therapeutics Announces Director Resignation

* ‍DOUG BANZET HAS RESIGNED FROM COMPANY'S BOARD OF DIRECTORS​ Source text for Eikon: Further company coverage:

17 Jan 2018

BRIEF-‍Aurora Purchases 10,800 Shares Of Cannimed Therapeutics Inc.​

* ‍AURORA PURCHASES 10,800 SHARES OF CANNIMED THERAPEUTICS INC.​ Source text for Eikon: Further company coverage:

16 Jan 2018

BRIEF-Cannimed Says Glass Lewis Recommends Co's Shareholders Vote For Newstrike Deal

* A SECOND LEADING INDEPENDENT PROXY ADVISOR, GLASS LEWIS, RECOMMENDS CANNIMED SHAREHOLDERS VOTE “FOR” THE NEWSTRIKE ACQUISITION

15 Jan 2018

Earnings vs. Estimates